This inventor holds 1 USPTO granted patent. Top assignee: Nurix Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Dahlia Weiss: Innovator in CBL-B Inhibition
Introduction
Dahlia Weiss is a prominent inventor known for her contributions to the field of medicinal chemistry. She has made significant strides in developing compounds that target specific biological pathways. Her work is particularly focused on CBL-B inhibition, which has implications for various therapeutic applications.
Latest Patents
Dahlia holds a patent for "3-Substituted Piperidine Compounds for CBL-B Inhibition, and Use Thereof." This patent highlights her innovative approach to creating compounds that can potentially enhance therapeutic efficacy in treating diseases related to immune response.
Career Highlights
Dahlia Weiss is currently employed at Nurix Therapeutics, Inc., where she continues to advance her research in drug development. Her expertise in medicinal chemistry has positioned her as a valuable asset in the pharmaceutical industry.
Collaborations
Dahlia collaborates with notable colleagues, including Mario G. Cardozo and Frederick Cohen. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in drug discovery.
Conclusion
Dahlia Weiss exemplifies the spirit of innovation in the pharmaceutical field. Her work on CBL-B inhibition and her collaborations with esteemed colleagues underscore her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile